Pepa Bruce

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Chronic Obstructive Pulmonary Disease

Top Venues

ERJ open research

The European respiratory journal

Respirology (Carlton, Vic.)

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tasmin Barry, Mark Holliday, Jenny Sparks, Rowan Biggs, Atalie Colman, Rebekah Lamb, Karen Oldfield, Nick Shortt, Kyley Kerse, John Martindale, Allie Eathorne, Michaela Walton, Bianca Black, Matire Harwood, Pepa Bruce, Ruth Semprini, Andrew Bush, Louise J Fleming, Catherine A Byrnes, David McNamara, Lee Hatter, Stuart R Dalziel, Mark Weatherall, Richard Beasley
START CARE: a protocol for a randomised controlled trial of step-wise budesonide-formoterol reliever-based treatment in children. ERJ open research 10 (2) (2024)
Lee Hatter, Mark Holliday, Allie Eathorne, Pepa Bruce, Ian D Pavord, Helen K Reddel, Robert J Hancox, Alberto Papi, Mark Weatherall, Richard Beasley
The carbon footprint of as-needed budesonide-formoterol in mild asthma: a post hoc analysis. The European respiratory journal (2024)
Tasmin Barry, Mark Holliday, Jenny Sparks, Rowan Biggs, Atalie Colman, Rebekah Lamb, Karen Oldfield, Nick Shortt, Kyley Kerse, John Martindale, Allie Eathorne, Michaela Walton, Bianca Black, Matire Harwood, Pepa Bruce, Ruth Semprini, Andrew Bush, Louise J Fleming, Catherine A Byrnes, David McNamara, Lee Hatter, Stuart R Dalziel, Mark Weatherall, Richard Beasley
START CARE: a protocol for a randomised controlled trial of step-wise budesonide-formoterol reliever-based treatment in children. ERJ open research 10 (2) (2024)
Lee Hatter, Mark Holliday, Allie Eathorne, Pepa Bruce, Ian D Pavord, Helen K Reddel, Robert J Hancox, Alberto Papi, Mark Weatherall, Richard Beasley
The carbon footprint of as-needed budesonide/formoterol in mild asthma: a post hoc analysis. The European respiratory journal 64 (1) (2024)
Pepa Bruce, Lee Hatter, Claire Houghton, Ciléin Kearns, Mark Holliday, Augustus J Anderson, Allie Eathorne, John Martindale, Alex Semprini, Mark Weatherall, Ian Pavord, Tim Harrison, Alberto Papi, Rob Horne, Richard Beasley
The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthma. ERJ open research 9 (5) (2023)
Lee Hatter, Pepa Bruce, Richard Beasley
A breath of fresh AIR: reducing the carbon footprint of asthma. Journal of medical economics 25 (1) (2022)
Pepa Bruce, Kate Ainscough, Lee Hatter, Irene Braithwaite, Lindsay R Berry, Mark Fitzgerald, Thomas Hills, Kathy Brickell, David Cosgrave, Alex Semprini, Susan Morpeth, Scott Berry, Peter Doran, Paul Young, Richard Beasley, Alistair Nichol
Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses. Trials 23 (1) (2022)
Lee Hatter, Pepa Bruce, Mark Holliday, Augustus J Anderson, Irene Braithwaite, Andrew Corin, Allie Eathorne, Arthur Grimes, Matire Harwood, Thomas E Hills, Ciléin Kearns, Kyley Kerse, John Martindale, Barney Montgomery, Lynn Riggs, Davitt Sheahan, Nick Shortt, Katja Zazulia, Mark Weatherall, David McNamara, Catherine A Byrnes, Andrew Bush, Stuart R Dalziel, Richard Beasley
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma. ERJ open research 7 (4) (2021)
Richard Beasley, Pepa Bruce, Lee Hatter, Irene Braithwaite, Alex Semprini, Ciléin Kearns, Mark Weatherall, Ian Douglas Pavord
A Proposed Revision of the Stepwise Treatment Algorithm in Asthma. American journal of respiratory and critical care medicine 204 (1) (2021)
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis. ERJ open research 7 (1) (2021)
Pepa Bruce, Lee Hatter, Richard Beasley
Anti-inflammatory reliever therapy in asthma: The evidence mounts but more is needed. Respirology (Carlton, Vic.) 25 (8) (2020)